Clinical Trials Industry Leader, Dawn Furey, Joins Circuit Clinical as Chief Clinical Operations Officer
Wednesday, March 2, 2022
Source: Circuit Clinical
BUFFALO, NY – Continuing its rapid expansion and focus on key talent acquisition, Circuit Clinical proudly announces the addition of clinical trials thought leader, Dawn Furey, as its first-ever Chief Clinical Operations Officer. Dawn joins Circuit Clinical’s executive team to oversee and accelerate operational scale throughout the company’s national expansion.
Dawn’s storied career of landmark achievements in drug development at both Merck and Janssen, the pharmaceutical arm of Johnson & Johnson, include:
- Her operational leadership within Operation Warp Speed on behalf of Johnson & Johnson to develop their COVID-19 vaccine and enroll 45,000 patients within 8 weeks.
- Her executive success in implementing disruptive, transformational processes within clinical development to accelerate study start-up times, predictably enroll clinical trial patients, and drive diversity within participants – seen throughout the Merck & Janssen portfolios.
- Her breakthrough leadership in the expansion of clinical research throughout Eastern Europe and Russia, optimizing the footprint of trials in underutilized geographies and expanding access to clinical trials as a care option.
“As we look to the incredible impact that we can have on patients everywhere, we are actively recruiting the talent that will transform Circuit Clinical into an industry leader in improving access and inclusion within clinical trials. Dawn Furey is exactly that kind of leader,” noted CEO & Founder, Irfan Khan, MD. “Her career is a testament to the power of being totally focused on clinical delivery and operational excellence. Dawn’s insights and expertise in leading our national expansion will transform our ability to impact the greatest number of patients, providers, and health systems.”
As Chief Clinical Operations Officer, Dawn will have hands-on leadership in all efforts to expand Circuit’s operational capabilities; optimize clinical trial timelines using data analytics; enhance patient recruitment and retention strategies; and ensure quality and compliance across our clinical trial portfolio. Dawn’s direct experience with diversity, equity, and inclusion initiatives will also play a key role in how Circuit Clinical grows to carry out its mission of transforming access, inclusion, and patient experiences within clinical research.
Says Dawn, “I am energized and deeply inspired by this opportunity at Circuit Clinical. What this team and vision can do for the industry is uncharted; this is the start of our journey to truly provide clinical research opportunities to patients everywhere.”